Evolution of H7N9

Genetic diversity helped avian influenza A viruses make the leap from birds to humans, researchers report.

Written byErin Weeks
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

SXC.HU, PATRIZIO MARTORANAA team of Chinese researchers has shed light on how avian influenza A viruses like H7N9 spread to humans by sequencing viral genomes and piecing together the pathogen’s evolutionary history. The study, published this week (September 19) in Cell Host & Microbe, suggests two reassortment events were likely responsible for the virus’s genetic diversity.

Since March, global health officials have been keeping a close eye on China, where H7N9 made its first-ever leap from domestic birds to humans. More than 130 cases of infection had been reported by July, about a fifth of which were fatal. Most cases were contracted through direct contact with infected poultry, as the virus remains inefficient at human-to-human transmission. Just one mutation could help the virus overcome that barrier, however, which underscores the importance of understanding avian flu’s genetic variability and evolutionary history.

“A deep understanding of how the novel H7N9 viruses were generated is of critical importance for formulating proper measures for surveillance and control of these viruses and other potential emerging influenza viruses,” said Taijiao Jiang, a senior author of the study ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies